Paul Knight
Stock Analyst at Keybanc
(2.68)
# 2,048
Out of 4,734 analysts
130
Total ratings
45.37%
Success rate
3.74%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Maintains: Overweight | $30 → $33 | $26.14 | +26.24% | 5 | Dec 13, 2024 | |
| CSTL Castle Biosciences | Maintains: Overweight | $28 → $36 | $24.94 | +44.35% | 7 | Nov 5, 2024 | |
| DHR Danaher | Maintains: Overweight | $290 → $310 | $238.36 | +30.06% | 9 | Oct 23, 2024 | |
| RGEN Repligen | Maintains: Overweight | $210 → $220 | $160.51 | +37.06% | 7 | Feb 15, 2024 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $440 → $470 | $336.34 | +39.74% | 10 | Feb 13, 2024 | |
| RVTY Revvity | Maintains: Overweight | $110 → $126 | $118.39 | +6.43% | 2 | Feb 2, 2024 | |
| CDMO Avid Bioservices | Maintains: Overweight | $20 → $14 | $12.39 | +12.99% | 5 | Dec 8, 2023 | |
| TECH Bio-Techne | Maintains: Overweight | $115 → $80 | $75.83 | +5.50% | 8 | Nov 1, 2023 | |
| TMO Thermo Fisher | Downgrades: Sector Weight | n/a | $559.65 | - | 6 | Oct 26, 2023 | |
| STVN Stevanato Group | Maintains: Overweight | $35 → $37 | $22.85 | +61.93% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $4.77 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $7.50 | - | 8 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $8.07 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4 | $1.77 | +125.99% | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $147.36 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $52.63 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $7 | $1.93 | +262.69% | 4 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $22.11 | +80.91% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $17 | $3.99 | +326.07% | 5 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $163.50 | +83.49% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $197.36 | +26.67% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.08 | - | 2 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $181.27 | +143.28% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $163.87 | +44.02% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $93.27 | +6.14% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $15.92 | +245.48% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $404.00 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $40.58 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $139.61 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $136.67 | - | 5 | Oct 23, 2017 |
BioLife Solutions
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $26.14
Upside: +26.24%
Castle Biosciences
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $24.94
Upside: +44.35%
Danaher
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $238.36
Upside: +30.06%
Repligen
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $160.51
Upside: +37.06%
West Pharmaceutical Services
Feb 13, 2024
Maintains: Overweight
Price Target: $440 → $470
Current: $336.34
Upside: +39.74%
Revvity
Feb 2, 2024
Maintains: Overweight
Price Target: $110 → $126
Current: $118.39
Upside: +6.43%
Avid Bioservices
Dec 8, 2023
Maintains: Overweight
Price Target: $20 → $14
Current: $12.39
Upside: +12.99%
Bio-Techne
Nov 1, 2023
Maintains: Overweight
Price Target: $115 → $80
Current: $75.83
Upside: +5.50%
Thermo Fisher
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $559.65
Upside: -
Stevanato Group
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $22.85
Upside: +61.93%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $4.77
Upside: -
Jul 17, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $7.50
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $8.07
Upside: -
Jul 12, 2023
Initiates: Overweight
Price Target: $4
Current: $1.77
Upside: +125.99%
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $147.36
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $52.63
Upside: -
Apr 26, 2023
Maintains: Overweight
Price Target: $5 → $7
Current: $1.93
Upside: +262.69%
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $22.11
Upside: +80.91%
May 13, 2022
Maintains: Overweight
Price Target: $20 → $17
Current: $3.99
Upside: +326.07%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $163.50
Upside: +83.49%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $197.36
Upside: +26.67%
Mar 14, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $2.08
Upside: -
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $181.27
Upside: +143.28%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $163.87
Upside: +44.02%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $93.27
Upside: +6.14%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $15.92
Upside: +245.48%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $404.00
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $40.58
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $139.61
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $136.67
Upside: -